Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial.
Zimerman A, Wiviott SD, Park JG, Murphy SA, Ran X, Bramson CR, Curto M, Ramos V, Jevne A, Kuder JF, Verma S, Wojakowski W, Terra SG, Sabatine MS, Bergmark BA, Marston NA. Zimerman A, et al. Among authors: verma s. Eur J Prev Cardiol. 2024 Mar 14:zwae090. doi: 10.1093/eurjpc/zwae090. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38484368
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.
Zimerman A, Wiviott SD, Park JG, Murphy SA, Ran X, Bramson CR, Curto M, Ramos V, Jevne A, Kuder JF, Verma S, Wojakowski W, Terra SG, Sabatine MS, Bergmark BA, Marston NA. Zimerman A, et al. Among authors: verma s. J Clin Lipidol. 2024 Mar-Apr;18(2):e261-e268. doi: 10.1016/j.jacl.2023.12.001. Epub 2023 Dec 10. J Clin Lipidol. 2024. PMID: 38158248 Clinical Trial.
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Jensen TJ, Einfeldt MN, Liisberg K, Perna E, Sharma K, Ezekowitz JA, Fu M, Melenovský V, Ito H, Lelonek M, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators. Petrie MC, et al. Among authors: verma s. J Am Coll Cardiol. 2024 May 13:S0735-1097(24)07020-7. doi: 10.1016/j.jacc.2024.04.022. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38819334
Perilous paradigm of graphene oxide and its derivatives in biomedical applications: Insight to immunocompatibility.
Ayreen Z, Khatoon U, Kirti A, Sinha A, Gupta A, Lenka SS, Yadav A, Mohanty R, Naser SS, Mishra R, Chouhan RS, Samal SK, Kaushik NK, Singh D, Suar M, Verma SK. Ayreen Z, et al. Among authors: verma sk. Biomed Pharmacother. 2024 May 28;176:116842. doi: 10.1016/j.biopha.2024.116842. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38810404 Review.
6,429 results